H. B. Fuller (FUL) Stock Rating Lowered by Zacks Investment Research
H. B. Fuller (NYSE:FUL) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday.
According to Zacks, “H.B. Fuller Company is a worldwide manufacturer and marketer of adhesives, sealants, coatings, paints and other specialty chemical products. The company’s largest worldwide business category is adhesives, sealants and coatings. These products are sold to customers in a wide range of industries, including packaging, woodworking, automotive, aerospace, graphic arts (books/magazines), appliances, filtration, windows, sporting goods, nonwovens, shoes and ceramic tile. “
FUL has been the topic of a number of other research reports. Robert W. Baird assumed coverage on shares of H. B. Fuller in a research report on Thursday, September 14th. They set a “neutral” rating and a $60.00 price objective on the stock. Citigroup cut shares of H. B. Fuller from a “buy” rating to a “neutral” rating and set a $60.00 target price for the company. in a report on Tuesday, October 31st. ValuEngine cut shares of H. B. Fuller from a “buy” rating to a “hold” rating in a report on Friday, November 10th. KeyCorp reaffirmed a “hold” rating on shares of H. B. Fuller in a report on Thursday, August 24th. Finally, Deutsche Bank upped their target price on shares of H. B. Fuller from $56.00 to $58.00 and gave the company a “hold” rating in a report on Wednesday, September 6th. One research analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $60.00.
H. B. Fuller (NYSE:FUL) last announced its quarterly earnings data on Wednesday, September 27th. The specialty chemicals company reported $0.65 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.67 by ($0.02). The business had revenue of $562.87 million during the quarter, compared to analysts’ expectations of $553.66 million. H. B. Fuller had a return on equity of 13.08% and a net margin of 4.76%. research analysts expect that H. B. Fuller will post 2.6 EPS for the current fiscal year.
In related news, VP Traci L. Jensen sold 5,397 shares of the firm’s stock in a transaction on Monday, October 2nd. The shares were sold at an average price of $58.40, for a total transaction of $315,184.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Timothy J. Keenan sold 6,500 shares of the firm’s stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $55.08, for a total transaction of $358,020.00. Following the transaction, the vice president now directly owns 29,611 shares of the company’s stock, valued at $1,630,973.88. The disclosure for this sale can be found here. Insiders have sold 15,767 shares of company stock valued at $897,394 over the last ninety days. 3.10% of the stock is currently owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. lifted its position in H. B. Fuller by 0.6% during the second quarter. BlackRock Inc. now owns 6,252,664 shares of the specialty chemicals company’s stock valued at $319,575,000 after purchasing an additional 34,858 shares during the last quarter. Vanguard Group Inc. lifted its position in H. B. Fuller by 1.0% during the second quarter. Vanguard Group Inc. now owns 5,108,535 shares of the specialty chemicals company’s stock valued at $261,098,000 after purchasing an additional 53,030 shares during the last quarter. Janus Henderson Group PLC bought a new position in H. B. Fuller during the second quarter valued at $105,912,000. Dimensional Fund Advisors LP lifted its position in H. B. Fuller by 0.6% during the third quarter. Dimensional Fund Advisors LP now owns 2,032,726 shares of the specialty chemicals company’s stock valued at $118,020,000 after purchasing an additional 13,051 shares during the last quarter. Finally, Macquarie Group Ltd. lifted its position in H. B. Fuller by 7.2% during the third quarter. Macquarie Group Ltd. now owns 1,698,348 shares of the specialty chemicals company’s stock valued at $98,606,000 after purchasing an additional 114,635 shares during the last quarter. Institutional investors and hedge funds own 92.35% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “H. B. Fuller (FUL) Stock Rating Lowered by Zacks Investment Research” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/12/11/h-b-fuller-ful-stock-rating-lowered-by-zacks-investment-research.html.
About H. B. Fuller
H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for H. B. Fuller Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller Company and related companies with MarketBeat.com's FREE daily email newsletter.